Skip to main content

Table 1 Characteristics of 310 adults with HIV evaluated for pulmonary tuberculosis, Nigeria (June 2013- June 2015)

From: Evaluation of gene xpert for routine diagnosis of HIV-associated tuberculosis in Nigeria: A prospective cohort study

Characteristics

Total Population

(n = 310)

Treated for TB

(n = 76)

No evidence of TB

(n = 234)

P-value

Age,years, Mean (SD)

38.5 (10.6)

35.7 (9.6)

39.4 (10.7)

0.007

Sex

   

0.03

 Male, n (%)

115 (37.1)

36 (47.4)

79 (33.8)

 

 Female, n (%)

195 (62.9)

40 (52.6)

155 (66.2)

 

Body Mass Index

21.9 (3.9)

20.9 (3.8)

22.3 (3.9)

0.02

TB symptoms

 †Cough duration,Weeks, Median (IQR)

3 (2–6)

4 (2–8)

3 (2–5)

0.002

 Fever, n (%)

227 (73.2)

62 (81.6)

165 (70.5)

0.06

 Weight loss, n (%)

250 (80.6)

67 (88.2)

183 (78.2)

0.06

 Night Sweat, n (%)

209 (67.4)

56 (73.7)

153 (65.4)

0.18

 Cough > 2 weeks, n (%)

195 (62.9)

56 (73.7)

139 (59.4)

0.03

Previous TB treatment, n (%)

81 (26.1)

11 (14.5)

70 (29.9)

0.008

On ART, n (%)

273 (88.1)

63 (82.9)

210 (89.1)

0.34

†Latest CD4 Count, cells/mm3, (Median, IQR)

242 (120–425)

224 (99–354)

259 (128–457)

0.11

  1. SD Standard deviation, IQR Interquartile range, TB Tuberculosis, ART Antiretroviral Therapy, †Mann Whitney U test